Influence of emulsifiers on the formation and in vitro anticancer activity of epirubicin loaded PLGA nanoparticles

Rizvi, 2018, Applications of nanoparticle systems in drug delivery technology, Saudi Pharmaceut. J., 26, 64, 10.1016/j.jsps.2017.10.012 Mu, 2003, PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio, Pharmaceut. Res., 20, 1864, 10.1023/B:PHAM.0000003387.15428.42 Moghimi, 2001, Long-circulating and target-specific nanoparticles: theory to practice, J. Pharm. Pharmacol., 53, 283 Lawrence, 2000, Microemulsion-based media as novel drug delivery systems, Adv. Drug Deliv. Rev., 45, 89, 10.1016/S0169-409X(00)00103-4 Sharma, 2016, Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: A co-surfactant study, Asian J. Pharm. Sci., 11, 404, 10.1016/j.ajps.2015.09.004 Scholes, 1993, The preparation of sub-200 nm poly (lactide-co-glycolide) microspheres for site-specific drug delivery, 25, 145 Saadati, 2014, Marked effects of combined TPGS and PVA emulsifiers in the fabrication of etoposide-loaded PLGA-PEG nanoparticles: in vitro and in vivo evaluation, Int. J. Pharm., 464, 135, 10.1016/j.ijpharm.2014.01.014 Maestrelli, 2011, Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components, 78, 385 Zhang, 2017, Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel, 12, 8779 Mu, 2002, Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol®), J. Contr. Release, 80, 129, 10.1016/S0168-3659(02)00025-1 Şengel, 2011, Design of vitamin E d-α-Tocopheryl polyethylene glycol 1000 succinate-emulsified poly (D, L–lactide–co-glycolide) nanoparticles: influence of duration of ultrasonication energy, J. Young Pharm., 3, 171, 10.4103/0975-1483.83754 Santander-Ortega, 2006, Colloidal stability of Pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms, 302, 522 Yan, 2010, The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity, 6, 170 Coukell, 1997, Epirubicin, Drugs, 53, 453, 10.2165/00003495-199753030-00008 Sahoo, 2002, Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, 82, 105 Azizi, 2013, Fabrication of protein-loaded PLGA nanoparticles: effect of selected formulation variables on particle size and release profile, 20, 110 Keum, 2011, Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid, Int. J. Nanomed., 6, 2225 Sahli, 1997, Interactions of poly (lactic acid) and poly (lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system, 18, 281 Brambilla, 2011, Colloidal properties of biodegradable nanoparticles influence interaction with amyloid-β peptide, 156, 338 Mu, 2003, A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS, J. Contr. Release, 86, 33, 10.1016/S0168-3659(02)00320-6 Feczkó, 2008, Comparison of the preparation of PLGA–BSA nano-and microparticles by PVA, poloxamer and PVP, 319, 188 Vandervoort, 2002, Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study, Int. J. Pharm., 238, 77, 10.1016/S0378-5173(02)00058-3 Budhian, 2007, Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content, Int. J. Pharm., 336, 367, 10.1016/j.ijpharm.2006.11.061 Shen, 2012, Accelerated in‐vitro release testing methods for extended‐release parenteral dosage forms, J. Pharm. Pharmacol., 64, 986, 10.1111/j.2042-7158.2012.01482.x Esmaeili, 2008, PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution, 349, 249 Chavanpatil, 2007, Polymer‐surfactant nanoparticles for sustained release of water‐soluble drugs, 96, 3379 Bouissou, 2006, The influence of surfactant on PLGA microsphere glass transition and water sorption: remodeling the surface morphology to attenuate the burst release, 23, 1295 Kumar, 2004, Preparation and characterization of cationic PLGA nanospheres as DNA carriers, Biomaterials, 25, 1771, 10.1016/j.biomaterials.2003.08.069 Sahoo, 2002, Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, J. Contr. Release, 82, 105, 10.1016/S0168-3659(02)00127-X Menon, 2012, Effects of surfactants on the properties of PLGA nanoparticles, J. Biomed. Mater. Res., 100, 1998, 10.1002/jbm.a.34040 Symonds, 2005, Low and high molecular weight poly (l‐lysine) s/poly (l‐lysine)–DNA complexes initiate mitochondrial‐mediated apoptosis differently, 579, 6191